Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests if speedy C-Section recovery boosts Parent-Baby bonding

NCT ID NCT07276126

Symptom relief Sponsor: Okan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether the Enhanced Recovery After Cesarean (ERAS) protocol helps mothers and fathers bond better with their newborn. ERAS includes steps like shorter fasting, early eating and walking, and immediate skin-to-skin contact. The trial will enroll 300 families and measure bonding through questionnaires at several time points after delivery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Enhanced Recovery After Cesarean (ERAS) protocol
What this could lead to
If it works, this could show that a simple set of recovery steps helps new parents feel closer to their baby after a C-section.
What could go wrong
This is a small, early-stage study with only 1 participant enrolled so far. The results may not apply to all hospitals or families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1 person

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

IInclusion Criteria: Pregnant women aged 18-60 years. Singleton, live fetus, and ≥37 weeks of gestation. Undergoing elective or medically indicated cesarean delivery. Ability to read and understand Turkish (for questionnaire validity). Mothers and fathers willing and able to complete postpartum follow-up assessments (2 hours, 24 hours, day 4, day 7). Provision of written informed consent by mother and, if participating, by father/partner. Maternal postpartum clinical stability (no condition precluding questionnaire completion). ❌ Exclusion Criteria (Dışlanma Kriterleri) Exclusion Criteria: Preterm birth (\<37 weeks) or multiple gestation (twins, triplets). Stillbirth, early neonatal death, or major congenital anomaly. Newborn requiring prolonged NICU stay preventing bonding assessments. Maternal severe obstetric complications: Massive postpartum hemorrhage Hysterectomy Severe preeclampsia or eclampsia Severe postpartum infection Maternal active psychiatric disorder or use of psychotropic medication. Maternal need for high-dose opioid analgesia or sedation interfering with bonding assessments. Inability to read/understand Turkish or cognitive impairment preventing questionnaire completion. Failure to complete follow-up visits (2 hours, 24 hours, day 4, day 7). Withdrawal of consent at any time.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bonding are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bonding Cesarean section ERAS Father-child relations Maternal care Mother-infant interaction

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Istanbul Okan University Hospital

    RECRUITING

    Istanbul, 34947, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.